UNSPSC 51171652: Prucalopride hydrochloride

This classification denotes a serotonin agonist C18H26ClN3O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M8IYX9Z79V, chemically known as 4-amino-5-chloro-2,3-dihydro-n-(1-(3-methoxypropyl)-4-piperidinyl)-7-benzofurancarboxamide hydrochloride, but more generally known as prucalopride hydrochloride, which bears US NIH Compound Identifier 9931054. Most nations, for tariff and trade purposes, schedule prucalopride hydrochloride under HS 29349990 and SITC 51579.

As of Q4 2014, PRUCALOPRIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: COCCCN1CCC(CC1)NC(=O)C2CC(C(C3C2OCC3)N)CL.CL.

UNSPSC 51171652 Prucalopride hydrochloride is a Commodity code representing a specific pharmaceutical active ingredient, but the recent state and local opportunities tagged under it do not reflect direct procurement of this drug. Instead, the code's recent activity encompasses broader pharmaceutical and drug-testing services: offender specimen collection and drug screening, therapeutic pharmacy initiatives involving direct manufacturer relationships, and generic multi-source pharmaceutical distribution through cooperative purchasing vehicles. State and local issuing bodies procuring under this code include county corrections departments (Collin County Community Supervision and Corrections Department), state health and human services agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances serving state and local government facilities (Minnesota Multistate Cooperative Purchasing Alliance). The scope of work involves lab-certified drug testing with immunoassay and confirmation methodologies, pharmacy benefit management and direct-to-manufacturer prescription fulfillment, and vendor capacity to supply generic pharmaceuticals with cGMP and Drug Supply Chain Security Act compliance through authorized pharmaceutical wholesalers.

Recent activity spans Texas and Minnesota. Collin County's RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026, reflects an estimated contract value of $600,000 over two years with three optional one-year renewals, requiring SAMHSA, Texas DPS, or CAP lab certification and per-test pricing models covering screening and confirmation across collection sites in Plano and McKinney. The Texas Health and Human Services Commission issued RFI HHS0017013 in March 2026 to gather market intelligence on direct-to-manufacturer prescription programs supporting self-insured employer and state agency health plans, signaling early-stage procurement planning with no award value identified. The Minnesota Department of Administration's MMCAP cooperative purchasing RFP S1070000015802, due March 26, 2026, established contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with evaluation weighted 75 percent on price competitiveness and 25 percent on administrative, compliance, and capability factors including cGMP certification and insurance requirements of $5 million commercial general liability and $2 million network security and professional liability coverage per occurrence.